Hyperbranched Polyplexes for Low-Toxicity DNA and RNA Delivery
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current methods for delivering DNA or RNA, such as miRNA, face challenges due to low transfection efficiency, rapid degradation, and adverse immune responses, particularly with viral vectors, while non-viral carriers like PEI face toxicity and efficiency issues depending on molecular weight.
Innovation Solution
Hyperbranched polymers combining low molecular weight cationic PEI, linear or hyperbranched polyester, and PEG chains form self-assembling polyplexes that can be encapsulated in biodegradable microspheres for controlled two-stage gene delivery, reducing toxicity and enhancing transfection efficiency.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If viral vectors are used to deliver miRNA, then transfection efficiency is improved, but adverse immune response increases
Solution Approach 1:
The patent introduces non-viral polymeric carriers (hyperbranched polymers, dendrimers, block copolymers) as intermediary substances to deliver miRNA without using viral vectors. These synthetic carriers mediate the delivery process, achieving transfection efficiency while avoiding the immune response associated with viral vectors.
Solution Approach 2:
The patent employs biodegradable polymeric carriers that are designed to be temporary and disposable. These polymers degrade after delivering their cargo, avoiding persistent immune responses. Examples include PLGA-based carriers and other biodegradable polymers mentioned in the patent.
2Reliability
If PEI with high molecular weight is used, then transfection efficiency is improved, but cell toxicity increases
Solution Approach 1:
The patent systematically changes the molecular weight parameter of PEI and develops alternative polymers with optimized parameters. It identifies that low molecular weight PEI (2000 g/mol or less) provides adequate transfection efficiency with reduced toxicity, and further develops hyperbranched polymers and dendrimers with tailored molecular weights and structures to optimize the efficiency-toxicity ratio.
Solution Approach 2:
The patent creates composite polymeric systems combining different polymer components with complementary properties. Examples include block copolymers combining cationic blocks for DNA binding with hydrophilic blocks for reduced toxicity, and core-shell structures where the core provides transfection function while the shell reduces toxicity and improves biocompatibility.
3Reliability
If chemical modifications are made to miRNA, then stability and transfection efficiency are improved, but availability decreases and cost increases
Solution Approach 1:
The patent develops universal polymeric carrier platforms that can deliver multiple different miRNA sequences without requiring specific chemical modifications for each miRNA. The hyperbranched polymers and dendrimers with multiple surface functional groups can complex with various miRNAs using the same delivery mechanism, making the system universally applicable and simplifying manufacturing.
4Reliability
If oral administration of NR4A1 is used, then treatment of fibrosis is achieved, but nonspecific toxicity increases
Solution Approach 1:
The patent employs targeted delivery systems that concentrate the therapeutic miRNA at specific disease sites rather than distributing it systemically. The polymeric carriers are designed to accumulate at fibrotic lesions through passive targeting (exploiting the enhanced permeability and retention effect) or active targeting (using ligands that bind to receptors overexpressed at fibrotic sites), thereby achieving local high concentration with minimal systemic toxicity.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
The hyperbranched polymers provide high transfection efficiency and controlled release of DNA or RNA, minimizing toxicity and unintended delivery to off-target cells, promoting spatial and temporal activation of endogenous cells for tissue regeneration.
Implementation Method 1
low molecular weight cationic PEI, linear orhyperbranched polyester, and PEG chains form self-assembling polyplexes
Implementation Method 2
encapsulated in biodegradable microspheres for controlled two-stage gene delivery
Implementation Method 3
biodegradable microspheres
Data Source
Figure 1~2
Figure 3A
Figure 3B
AI summary
A hyperbranched polymer includes a hyperbranched, hydrophobic molecular core, respective low molecular weight polyethyleneimine chains attached to at least three branches of the hyperbranched, hydrophobic molecular core, and respective polyethylene glycol chains attached to at least two other branches of the hyperbranched, hydrophobic molecular core. Examples of the hyperbranched polymer may be used to form hyperbranched polyplexes, and may be included in DNA or RNA delivery systems.